Tate & Lyle plc (BD15.L) manufactures and supplies specialty food and beverage ingredients derived from agricultural commodities. The company offers a broad portfolio of products including texturants such as starches, gums and fibres; sweeteners encompassing allulose, sucralose, stevia, syrups and sugar; fortification blends with vitamins, minerals and phytonutrients; and acidulants and flavours; along with enzymes, proteins and stabilisers for applications in beverages, dairy, bakery, snacks, soups, sauces and dressings. It serves multinational food and beverage manufacturers, as well as smaller brands, primarily in North America, Europe and international markets. Founded in 1921 through the merger of Henry Tate & Sons and Abram Lyle & Sons, the company is headquartered in London, United Kingdom. In recent developments, Tate & Lyle completed the acquisition of CP Kelco in 2024, significantly expanding its texturants portfolio with leading pectin, carrageenan and xanthan gum brands, and launched innovative allulose-based sweeteners and reduced-sugar solutions to meet growing demand for healthier formulations [web:previous]. The company also announced strategic investments in sustainable manufacturing facilities in the US and Europe during 2025 to support capacity growth and net-zero ambitions [web:previous].